← back to search

Christopher U. Jones

Sutter Medical Center · US
Area of research
Otorhinolaryngology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Head and Neck Cancer Studies, Prostate Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, and Lung Cancer Treatments and Mutations.
h-index
38
citations
17,124
works
119
NIH funding
primary concept
Medicine
email

Recent publications

Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.
2025cited by 6position: contributordoi
Supplementary Table S1 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S8 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S3 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S5 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S2 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S6 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Figure S2 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S7 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Data from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S4 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Figure S1 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
Supplementary Table S9 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
2025cited by 0position: contributordoi
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
European Urology Oncology 2024cited by 25position: middledoi
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
The Lancet Oncology 2024cited by 8position: middledoi
Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Clinical Cancer Research 2024cited by 7position: middledoi
Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer
International Journal of Radiation Oncology*Biology*Physics 2023cited by 12position: middledoi
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma
JAMA Oncology 2023cited by 11position: middledoi
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)
European Urology 2022cited by 60position: middledoi
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial.
2022cited by 30position: contributordoi
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Journal of Clinical Oncology 2021cited by 366position: middledoi
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
2021cited by 257position: contributordoi
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
The Lancet Oncology 2021cited by 106position: middledoi
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
International Journal of Radiation Oncology*Biology*Physics 2021cited by 41position: firstdoi
NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer
International Journal of Radiation Oncology*Biology*Physics 2019cited by 87position: middledoi
Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion
Journal of Clinical Oncology 2019cited by 72position: middledoi
ACR Appropriateness Criteria® Neck Mass-Adenopathy
Journal of the American College of Radiology 2019cited by 38position: middledoi
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
Clinical Cancer Research 2019cited by 28position: middledoi
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
The Lancet 2018cited by 1,284position: middledoi
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
The Lancet Oncology 2018cited by 229position: middledoi

Grants

Mid-scale RI-1 (M1:IP): Atmospheric Science and Chemistry mEasurement NeTwork (ASCENT)
NSF2131914$12,136,2322021–2026PIRePORTER
Mentored Access to Success in Undergraduate Science and Engineering Programs
NSF1834061$999,5142019–2024PIRePORTER
13th International Conference on Fundamentals of Adsorption, FOA13
NSF1915875$15,0002019–2020PIRePORTER
A Distributed Learning Environment for the Mathematics of Climate and Sustainability
NSF1722578$467,4802017–2023PIRePORTER
EAGER: PPER: Validation and Utilization of a New Tool for Citizen-Led Water Quality Monitoring in Agricultural Watersheds
NSF1743991$88,7142017–2018PIRePORTER
SusChEM:A novel route to an important monomer, 2,5 furandicarboxylic acid, using Carbon Dioxide captured from air
NSF1336386$913,8842014–2017PIRePORTER
Mentored Access to Programs in Science (MAPS)
NSF1354825$613,4772014–2019PIRePORTER
Collaborative Research: Characterizing Interactions of Carbon Dioxide with Tailored Adsorbing Materials for Capture of Carbon Dioxide from Power Plant Exhaust Gas and Ambient Air
NSF1403239$300,0002014–2018PIRePORTER
Geometric Criteria for (In)Stability
NSF1312906$450,0002013–2017PIRePORTER
Collaborative Research: Mathematics and Climate Change Research Network
NSF0940363$1,718,7232010–2017PIRePORTER
SGER: Collaborative Research: Creating a Climate Math Web Portal
NSF0839912$28,0002008–2010PIRePORTER
Functionalized Magnetic Nanoparticles as Polymerization Catalysts
NSF0553554$285,0002006–2010PIRePORTER
Permanent Structures Across Scales: Assessing Stability the Effects of Perturbations
NSF0410267$589,1672004–2011PIRePORTER
Pulse Dynamics in Optical Communications
NSF0341456$111,0002003–2005PIRePORTER
Collaborative Research: A General Purpose Tool for Acoustic Remote Sensing and Mapping of Hydrothermal Flow
NSF0136768$515,0002002–2005PIRePORTER
CAREER: Rational Design in Chemical Engineering, From Polymerization Catalysis to Product Engineering
NSF0133209$374,9922002–2007PIRePORTER
Pulse Dynamics in Optical Communications
NSF0205496$111,0002002–2004PIRePORTER
NER: Molecular Design of Magnetic Nanocatalysts
NSF0210460$98,9512002–2003PIRePORTER
Collaborative Research on High Bit-Rate Communication: From Mathematical Development to Fiber Design
NSF0073923$927,7792000–2004PIRePORTER
Development of Dynamical Systems Techniques with Applications in Nonlinear Optics and Oceanography
NSF9704906$240,0001997–2001PIRePORTER
U.S.-Germany Cooperative Research: Dynamical Systems with Applications in Nonlinear Optics
NSF9603293$27,5601997–2001PIRePORTER
Mathematical Sciences: The Development of Techniques and Applications of Dynamical Systems
NSF9403774$174,0001994–1998PIRePORTER
Mathematical Sciences: Geometric Approaches to the Stability of Travelling Waves & Other Problems
NSF9100085$124,0921991–1995PIRePORTER
Accelerator Physics for Undergraduates in Science and Engineering
NSF8851797$100,0001989–1990PIRePORTER
Mathematical Sciences: Dynamical Systems Methods in the Study of One Dimensional Wave Motion
NSF8801627$86,0941988–1991PIRePORTER

Frequent collaborators

Quynh‐Thu Le · Stanford University11 papers (2015–2024)Sue S. Yom · UCSF Helen Diller Family Comprehensive Cancer Center7 papers (2015–2023)Andy Trotti · The University of Texas Southwestern Medical Center7 papers (2014–2019)John A. Ridge · University of Colorado Denver7 papers (2014–2024)Adam S. Garden · University of Alabama at Birmingham6 papers (2014–2024)David I. Rosenthal · The University of Texas MD Anderson Cancer Center5 papers (2015–2024)Loren K. Mell · Johns Hopkins Medicine5 papers (2019–2021)Pedro A. Torres‐Saavedra · National Cancer Institute4 papers (2019–2024)Maura L. Gillison · Communities In Schools of Orange County4 papers (2018–2024)Alan C. Hartford · Dartmouth College4 papers (2015–2021)Min Yao · Guangxi University4 papers (2016–2021)Sharon A. Spencer · University of Alabama at Birmingham4 papers (2014–2023)James A. Bonner · University of Alabama at Birmingham4 papers (2015–2024)Paul M. Harari · University of Wisconsin–Madison4 papers (2016–2024)George Shenouda · McGill University Health Centre4 papers (2014–2023)Jeff M. Michalski · Washington University in St. Louis4 papers (2015–2021)Rathan M. Subramaniam · Indira Gandhi Institute of Child Health4 papers (2019–2021)Jonathan J. Beitler · St. Louis VA Medical Center4 papers (2014–2019)Jimmy J. Caudell · Moffitt Cancer Center3 papers (2019–2024)Dukagjin Blakaj · U-M Rogel Cancer Center3 papers (2018–2021)